Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Positive effects of PARP inhibitor in animal model of acute inflammation

Oct. 10, 2000

Advanced Biotherapy's anti-interferon gamma drug shows promise in the clinic

Oct. 10, 2000

Analgesic activity of S-19812 assessed in rodent models and reported at OARSI meeting

Oct. 9, 2000

Coulter obtains rights to technology related to RA treatment

Oct. 5, 2000

Japanese lab presents new inhibitors of TNF production

Oct. 4, 2000

Novartis reports success in developing orally active dual MMP/TNF-alpha inhibitors

Oct. 3, 2000

New class of oral TNF-alpha synthesis inhibitors presented at September conference

Oct. 3, 2000

Two new patents cover VCAM-1/VLA-4 inhibitors from Roche and their use

Oct. 2, 2000

Selective COX-2 inhibitor with promising profile emerges from Abbott R&D

Oct. 2, 2000

Submission of NDA for lupus therapy completed by Genelabs

Sep. 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...